AbbVie Products LLC
AbbVie Products LLC, a leading biopharmaceutical company headquartered in the United States, has established itself as a key player in the global healthcare industry since its founding in 2013. With a strong focus on immunology, oncology, neuroscience, and virology, AbbVie is renowned for its innovative therapies that address complex health challenges. The company’s flagship products, including Humira and Imbruvica, are distinguished by their unique mechanisms of action and proven efficacy, making significant impacts on patient care. AbbVie has achieved notable milestones, including strategic acquisitions and a robust pipeline of new treatments, solidifying its market position as a trusted provider of advanced medical solutions. With operations spanning North America, Europe, and beyond, AbbVie continues to drive advancements in healthcare, committed to improving patient outcomes worldwide.
DitchCarbon Score
How does AbbVie Products LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AbbVie Products LLC's score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AbbVie Products LLC's reported carbon emissions
AbbVie Products LLC, headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. As of now, there are no reported figures regarding their Scope 1, 2, or 3 emissions, which encompass direct and indirect greenhouse gas emissions associated with their operations. While the absence of detailed emissions data may suggest a lack of transparency, it is essential to note that many companies in the pharmaceutical industry are increasingly recognising the importance of climate commitments. AbbVie may be engaging in various sustainability initiatives, although specific details on their climate pledges or reduction strategies are not available at this time. In the context of the industry, companies are often encouraged to set science-based targets and align with global climate goals to mitigate their environmental impact. As such, AbbVie’s future commitments and actions in addressing climate change remain to be seen.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AbbVie Products LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
